INFOGRAPHIC: Navigating Treatments After ET + CDK4/6is and ET Limitations in ER+ HER2- ABC
This infographic summarizes the complex treatment landscape after progression or recurrence on ET+ CKD4/6 inhibitors in ER+, HER2-, ABC and the limitations for the 3 main classes of approved ETs
Date of Last Review: March 28, 2024
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice